» Authors » Yide Sun

Yide Sun

Explore the profile of Yide Sun including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 362
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun Y, Yu J, Chiu Y, Hsu Y
Front Public Health . 2022 Aug; 10:940800. PMID: 35991030
Internet information has become the main way for individuals to obtain health information. The purpose of this paper is to explore the role online information sources play in health decision-making....
2.
Chiu Y, Du J, Sun Y, Wang J
Front Psychol . 2022 Jun; 13:900360. PMID: 35719485
With advances in technology and the popularity of the Internet, consumers increasingly rely on various sources of electronic word-of-mouth (eWOM), such as online user reviews and critical reviews, in their...
3.
Wen Y, Trinh H, Linton C, Tani C, Norais N, Martinez-Guzman D, et al.
PLoS One . 2018 Apr; 13(4):e0194266. PMID: 29698406
The RV144 Phase III clinical trial with ALVAC-HIV prime and AIDSVAX B/E subtypes CRF01_AE (A244) and B (MN) gp120 boost vaccine regime in Thailand provided a foundation for the future...
4.
Bogers W, Barnett S, Oostermeijer H, Nieuwenhuis I, Beenhakker N, Mortier D, et al.
J Virol . 2017 Jul; 91(19). PMID: 28701402
Strategies are needed to improve the immunogenicity of HIV-1 envelope (Env) antigens (Ag) for more long-lived, efficacious HIV-1 vaccine-induced B-cell responses. HIV-1 Env gp140 (native or uncleaved molecules) or gp120...
5.
Vassell R, He Y, Vennakalanti P, Dey A, Zhuang M, Wang W, et al.
PLoS One . 2015 Jun; 10(6):e0128562. PMID: 26087072
The membrane proximal external region (MPER) of the gp41 subunit of the HIV-1 envelope glycoprotein (Env) contains determinants for broadly neutralizing antibodies and has remained an important focus of vaccine...
6.
Moscoso C, Xing L, Hui J, Hu J, Kalkhoran M, Yenigun O, et al.
Sci Rep . 2014 Nov; 4:7025. PMID: 25395053
Hypervariable loops of HIV-1 Env protein gp120 are speculated to play roles in the conformational transition of Env to the receptor binding-induced metastable state. Structural analysis of full-length Env-based immunogens,...
7.
Kassa A, Dey A, Sarkar P, LaBranche C, Go E, Clark D, et al.
PLoS One . 2013 Oct; 8(10):e76139. PMID: 24146829
Entry of HIV-1 into target cells requires binding of the viral envelope glycoprotein (Env) to cellular receptors and subsequent conformational changes that culminates in fusion of viral and target cell...
8.
Poon S, Moscoso C, Xing L, Kan E, Sun Y, Kolatkar P, et al.
AIDS . 2013 Jul; 27(15):2345-54. PMID: 23835500
Objective: To study the complex formed between Tat protein and Env soluble trimeric immunogen, and compare with previously determined structures of Env native trimers and Env-CD4m complexes. Design: The soluble...
9.
Dey A, Burke B, Sun Y, Hartog K, Heeney J, Montefiori D, et al.
Vaccine . 2012 Feb; 30(17):2749-59. PMID: 22366638
Identification of optimal antigen(s) and adjuvant combination(s) to elicit potent, protective, and long-lasting immunity has been a major challenge for the development of effective vaccines against chronic viral pathogens, such...
10.
Dey A, Burke B, Sun Y, Sirokman K, Nandi A, Hartog K, et al.
PLoS One . 2012 Feb; 7(1):e30233. PMID: 22291921
The identification of HIV-1 envelope glycoprotein (Env) structures that can generate broadly neutralizing antibodies (BNAbs) is pivotal to the development of a successful vaccine against HIV-1 aimed at eliciting effective...